These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31174822)

  • 1. Rituximab induction without maintenance for granulomatosis with polyangiitis and dialysis - Case report and literature review.
    Kolitz T; Tanay A; Biro A; Zandman-Goddard G
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):535-540. PubMed ID: 31174822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis.
    Puéchal X; Iudici M; Perrodeau E; Bonnotte B; Lifermann F; Le Gallou T; Karras A; Blanchard-Delaunay C; Quéméneur T; Aouba A; Aumaître O; Cottin V; Hamidou M; Ruivard M; Cohen P; Mouthon L; Guillevin L; Ravaud P; Porcher R; Terrier B;
    JAMA Netw Open; 2022 Nov; 5(11):e2243799. PubMed ID: 36441554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late recovery of renal function by rituximab in a patient with Wegener's granulomatosis.
    Malina M; Schaefer B; Waldherr R; Wühl E; Schaefer F; Schmitt CP
    Pediatr Nephrol; 2013 Mar; 28(3):511-4. PubMed ID: 23124537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous presentation of granulomatosis with polyangiitis (GPA) and immunoglobulin G4-related disease (IgG4-RD). Leaving an open question: widening the spectrum of a single disease or real overlap?
    Boncoraglio MT; Prieto-González S; Fernandes-Serodio J; Corral-Molina JM; Solé M; Hernández-Rodríguez J
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):108-112. PubMed ID: 33269656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulomatosis with polyangiitis (Wegener's).
    Puéchal X
    Joint Bone Spine; 2020 Dec; 87(6):572-578. PubMed ID: 32562697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.
    Cabral DA; Canter DL; Muscal E; Nanda K; Wahezi DM; Spalding SJ; Twilt M; Benseler SM; Campillo S; Charuvanij S; Dancey P; Eberhard BA; Elder ME; Hersh A; Higgins GC; Huber AM; Khubchandani R; Kim S; Klein-Gitelman M; Kostik MM; Lawson EF; Lee T; Lubieniecka JM; McCurdy D; Moorthy LN; Morishita KA; Nielsen SM; O'Neil KM; Reiff A; Ristic G; Robinson AB; Sarmiento A; Shenoi S; Toth MB; Van Mater HA; Wagner-Weiner L; Weiss JE; White AJ; Yeung RS;
    Arthritis Rheumatol; 2016 Oct; 68(10):2514-26. PubMed ID: 27111558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with similar biologic rituximab in 77 patients of granulomatosis with polyangiitis-a real-life experience.
    Mittal S; Naidu GSRSNK; Jha S; Rathi M; Nada R; Minz RW; Sharma K; Dhir V; Jain S; Sharma A
    Clin Rheumatol; 2021 Feb; 40(2):645-651. PubMed ID: 32656662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Rituximab on Refractory Organ Involvements in Granulomatosis with Polyangiitis: A Systematic Review of Case Reports.
    Hajishah H; Amini MJ; Chadeganipour AS; Salehi SA; Kazemi D
    Curr Rheumatol Rev; 2024; 20(3):270-283. PubMed ID: 37907486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.
    Teixeira V; Mohammad AJ; Jones RB; Smith R; Jayne D
    RMD Open; 2019; 5(1):e000905. PubMed ID: 31245051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Plasmapheresis and Immunosuppressants to Treat Diffuse Alveolar Hemorrhage in a Patient with Granulomatosis with Polyangiitis.
    Sattar Y; Susheela AT; Ullah W; Usman N; Zafrullah F
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31315254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
    Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
    J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blindness in a Sri Lankan woman with bilateral breast lumps: a case report.
    Bataduwaarachchi VR; Galappaththi R; Tissera N
    J Med Case Rep; 2015 Dec; 9():296. PubMed ID: 26714880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.